Jeffrey C. Moore

Jeffrey C. Moore

Top Cited Scholar 2026
Auto-generated profile, based on publicly available information

Jeffrey C. Moore

Process Research and Development, Merck & Co., Inc., Rahway, NJ, USA

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 June 2020 in Angewandte Chemie International Edition
Verified
Journal Article
Open access
PDF file
SWShuke Wu
Shuke Wu
RSRadka Snajdrova
Radka Snajdrova
JMJeffrey C. Moore
Jeffrey C. Moore
KBKai Baldenius
Kai Baldenius
Uwe T. BornscheuerUwe T. Bornscheuer
Uwe T. Bornscheuer
Biocatalysis has found numerous applications in various fields as an alternative to chemical catalysis. The use of enzymes in organic synthesis, especially to make chiral compounds for pharmaceuticals as well for the flavors and fragrance industry, are the most prominent examples. In addition, biocatalysts are used on a large scale to make specialty and even bulk chemicals. This review intends to give illustrative examples in this field with a special focus on scalable chemical production using enzymes. It also discusses the opportunities and limitations of enzymatic syntheses using distinct examples and provides an outlook on emerging enzyme classes.

24 November 2023 in Science
Verified
Journal Article
Closed access
RBRebecca Buller
Rebecca Buller
SLS. Lutz
S. Lutz
RKR. J. Kazlauskas
R. J. Kazlauskas
RSR. Snajdrova
R. Snajdrova
JMJ. C. Moore
J. C. Moore
Uwe T. BornscheuerUwe T. Bornscheuer
Uwe T. Bornscheuer
Biocatalysis harnesses enzymes to make valuable products. This green technology is used in countless applications from bench scale to industrial production and allows practitioners to access complex organic molecules, often with fewer synthetic steps and reduced waste. The last decade has seen an explosion in the development of experimental and computational tools to tailor enzymatic properties, equipping enzyme engineers with the ability to create biocatalysts that perform reactions not present in nature. By using (chemo)-enzymatic synthesis routes or orchestrating intricate enzyme cascades, scientists can synthesize elaborate targets ranging from DNA and complex pharmaceuticals to starch made in vitro from CO 2 -derived methanol. In addition, new chemistries have emerged through the combination of biocatalysis with transition metal catalysis, photocatalysis, and electrocatalysis. This review highlights recent key developments, identifies current limitations, and provides a future prospect for this rapidly developing technology.

6 December 2019 in Science
Verified
Journal Article
Closed access
PDF file
MHMark A. Huffman
Mark A. Huffman
AFAnna Fryszkowska
Anna Fryszkowska
OAOscar Alvizo
Oscar Alvizo
MBMargie Borra-Garske
Margie Borra-Garske
KCKevin R. Campos
Kevin R. Campos
HYHao Yang
Hao Yang
Maximal efficiency from enzyme cascades: Enzymes are highly selective catalysts that can be useful for specific transformations in organic synthesis. Huffman et al. combined designer enzymes in a multistep cascade reaction (see the Perspective by O'Reilly and Ryan). The approach eliminates purification steps, recycles expensive cofactors, and couples favorable and unfavorable reactions. With the target molecule islatravir, an experimental HIV drug, they optimized five enzymes by directed evolution to be compatible with unnatural substrates and stable in the reaction conditions. Stereochemical purity was amplified at every enzymatic step, and the final synthesis was both atom economical and efficient. Science , this issue p. 1255 ; see also p. 1199

1 December 2007 in Accounts of Chemical Research
Verified
Journal Article
Closed access
JMJeffrey C. Moore
Jeffrey C. Moore
DPDavid J. Pollard
David J. Pollard
BKBirgit Kosjek
Birgit Kosjek
PDPaul N. Devine
Paul N. Devine

23 December 2019 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
PDF file
DHDaniel A. Holland‐Moritz
Daniel A. Holland‐Moritz
MWMichael K. Wismer
Michael K. Wismer
BMBenjamin F. Mann
Benjamin F. Mann
IFIman Farasat
Iman Farasat
PDPaul Devine
Paul Devine
RKRobert T. Kennedy
Robert T. Kennedy

16 March 2022 in Nature
Verified
Journal Article
Closed access
PDF file
JMJohn A. McIntosh
John A. McIntosh
ZLZhijian Liu
Zhijian Liu
BABrian M. Andresen
Brian M. Andresen
NMNastaran Salehi Marzijarani
Nastaran Salehi Marzijarani
JMJeffrey C. Moore
Jeffrey C. Moore
MMMatthew L. Maddess
Matthew L. Maddess